National surveillance of invasive pneumococcal diseases in Taiwan, 2008-2012: Differential temporal emergence of serotype 19A

Vaccine

Volumn 32, Issue 27, 2014, Pages 3345-3349

  Chiang, Chuen Sheue ^a,b   Chen, Ying Yan ^a   Jiang, Shr Fong ^a   Liu, Ding Ping ^a   Kao, Pei Hsiu ^a   Teng, Hwa Jen ^a   Kuo, Tsung Lin ^a   Yao, Shu Man ^a   Tseng, Lei Ron ^a   Wang, Yu Lan ^a   Wu, Ho Sheng ^a   Chang, Feng Yee ^a,c   Lin, Tzou Yien ^d,e  

^a CENTER FOR DISEASE CONTROL   (Taiwan)

^b NATIONAL TAIPEI UNIVERSITY OF NURSING AND HEALTH SCIENCES   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^d Ministry of Health   (Taiwan)

^e CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Invasive pneumococcal disease; National surveillance; Serotype 19A; Streptococcus pneumoniae; Taiwan

Indexed keywords

PNEUMOCOCCUS VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CHILD; DISEASE SURVEILLANCE; FATALITY; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PNEUMOCOCCAL INFECTION; PREVALENCE; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; TAIWAN; CLASSIFICATION; EPIDEMIOLOGY; INFANT; INFECTION CONTROL; MIDDLE AGED; MORTALITY; PNEUMOCOCCAL INFECTIONS; PRESCHOOL CHILD; SENTINEL SURVEILLANCE; SEROTYPING; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DISEASE NOTIFICATION; HUMANS; INCIDENCE; INFANT; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; SENTINEL SURVEILLANCE; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; TAIWAN; YOUNG ADULT;

EID: 84901009920     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.04.061     Document Type: Article

References (28)

1. World Health Organization Pneumococcal vaccines; WHO position paper - 2012. Wkly Epidemiol Rec 2012, 87:129-144.
2. Randle E., Ninis N., Inwald D. Invasive pneumococcal disease. Arch Dis Child Educ Pract Ed 2011, 96(5):183-190.
3. Calix J.J., Porambo R.J., Brady A.M., Larson T.R., Yother J., Abeygunwardana C., et al. Biochemical, genetic, and serological characterization of two capsule subtypes among Streptococcus pneumoniae serotype 20 strains: discovery of a new pneumococcal serotype. J Biol Chem 2012, 287(33):27885-27894.
4. Jackson L.A., Neuzil K.M., Yu O., Benson P., Barlow W.E., Adams A.L., et al. Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med 2003, 348(18):1747-1755.
5. Miller E., Andrews N.J., Waight P.A., Slack M.P., George R.C. Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. Lancet Infect Dis 2011, 11(10):760-768.
6. Tyrrell G.J., Lovgren M., Chui N., Minion J., Garg S., Kellner J.D., et al. Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae pre- and post-seven valent pneumococcal conjugate vaccine introduction in Alberta, Canada, 2000-2006. Vaccine 2009, 27(27):3553-3560.
7. Rodenburg G.D., de Greeff S.C., Jansen A.G., de Melker H.E., Schouls L.M., Hak E., et al. Effects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands. Emerg Infect Dis 2010, 16(5):816-823.
8. Pilishvili T., Lexau C., Farley M.M., Hadler J., Harrison L.H., Bennett N.M., et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 2010, 201(1):32-41.
9. Vestrheim D.F., Lovoll O., Aaberge I.S., Caugant D.A., Hoiby E.A., Bakke H., et al. Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway. Vaccine 2008, 26(26):3277-3281.
10. Ruckinger S., van der Linden M., Reinert R.R., von Kries R., Burckhardt F., Siedler A. Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany. Vaccine 2009, 27(31):4136-4141.
11. Harboe Z.B., Valentiner-Branth P., Benfield T.L., Christensen J.J., Andersen P.H., Howitz M., et al. Early effectiveness of heptavalent conjugate pneumococcal vaccination on invasive pneumococcal disease after the introduction in the Danish Childhood Immunization Programme. Vaccine 2010, 28(14):2642-2647.
12. Hicks L.A., Harrison L.H., Flannery B., Hadler J.L., Schaffner W., Craig A.S., et al. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis 2007, 196(9):1346-1354.
13. http://www.ris.gov.tw/zh_TW/346.
14. Pebody R.G., Hellenbrand W., D'Ancona F., Ruutu P. Pneumococcal disease surveillance in Europe. Euro Surveill 2006, 11(9). pii:646.
15. Hsieh Y.C., Lin P.Y., Chiu C.H., Huang Y.C., Chang K.Y., Liao C.H., et al. National survey of invasive pneumococcal diseases in Taiwan under partial PCV7 vaccination in 2007: emergence of serotype 19A with high invasive potential. Vaccine 2009, 27(40):5513-5518.
16. Liao W.H., Lin S.H., Lai C.C., Tan C.K., Liao C.H., Huang Y.T., et al. Impact of pneumococcal vaccines on invasive pneumococcal disease in Taiwan. Eur J Clin Microbiol Infect Dis 2010, 29(4):489-492.
17. Hsieh Y.C., Chiu C.H., Chang K.Y., Huang Y.C., Chen C.J., Kuo C.Y., et al. The impact of the heptavalent pneumococcal conjugate vaccine on risk factors for Streptococcus pneumoniae carriage in children. Pediatr Infect Dis J 2012, 31(9):e163-e168.
18. Levine O.S., Farley M., Harrison L.H., Lefkowitz L., McGeer A., Schwartz B. Risk factors for invasive pneumococcal disease in children: a population-based case-control study in North America. Pediatrics 1999, 103(3):E28.
19. Takala A.K., Jero J., Kela E., Ronnberg P.R., Koskenniemi E., Eskola J. Risk factors for primary invasive pneumococcal disease among children in Finland. JAMA 1995, 273(11):859-864.
20. Thoon K.C., Chong C.Y., Tee N.W. Early impact of pneumococcal conjugate vaccine on invasive pneumococcal disease in Singapore children, 2005 through 2010. Int J Infect Dis 2012, 16(3):e209-e215.
21. Moore M.R., Gertz R.E., Woodbury R.L., Barkocy-Gallagher G.A., Schaffner W., Lexau C., et al. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J Infect Dis 2008, 197(7):1016-1027.
22. Chen Y.Y., Yao S.M., Chen Y.H., Jiang S.F., Kuo T.L., Kao P.H., et al. Antimicrobial susceptibility of invasive Streptococcus pneumoniae in Taiwan, 2008-2012. Taiwan Epidemiol Bull 2013, 29(19):232-242.
23. Kuo C.Y., Hwang K.P., Hsieh Y.C., Cheng C.H., Huang F.L., Shen Y.H., et al. Nasopharyngeal carriage of Streptococcus pneumoniae in Taiwan before and after the introduction of a conjugate vaccine. Vaccine 2011, 29(32):5171-5177.
24. Ho P.L., Chiu S.S., Ang I., Lau Y.L. Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae before and after introduction of 7-valent pneumococcal conjugate vaccine, Hong Kong, 1995-2009. Vaccine 2011, 29(17):3270-3275.
25. Green M.C., Mason E.O., Kaplan S.L., Lamberth L.B., Stovall S.H., Givner L.B., et al. Increase in prevalence of Streptococcus pneumoniae serotype 6C at eight children's hospitals in the United States from 1993 to 2009. J Clin Microbiol 2011, 49(6):2097-2101.
26. Yang J.R., Huang Y.P., Chang F.Y., Hsu L.C., Lin Y.C., Su C.H., et al. New variants and age shift to high fatality groups contribute to severe successive waves in the 2009 influenza pandemic in Taiwan. PLoS ONE 2011, 6(11):e28288.
27. Chuang J.H., Huang A.S., Huang W.T., Liu M.T., Chou J.H., Chang F.Y., et al. Nationwide surveillance of influenza during the pandemic (2009-10) and post-pandemic (2010-11) periods in Taiwan. PLoS ONE 2012, 7(4):e36120.
28. Louie J., Jean C., Chen T.H., Park S., Ueki R., Harper T., et al. Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009. Morb Mortal Wkly Rep 2009, 58(38):1071-1074.